Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio

Detalhes bibliográficos
Autor(a) principal: Flores, Ariane Ethur
Data de Publicação: 2017
Tipo de documento: Tese
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/17963
Resumo: Stroke is one of the most frequent neurologic diseases and involves various risk factors such as atherosclerosis, dyslipidemia and diabetes mellitus. Furthermore, the mechanisms of action associated with the pathophysiology of stroke involve multiple interaction pathways such as inflammation, oxidative stress, apoptosis, genetic factors and modulation of neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Studies has showed that genetics mutation as MnSOD Ala16Val single nucleotide polymorphism (SNP) to be associated to risk factors of vascular diseases, as well as with modulation of inflammation and oxidative pathways. However, little is known about the relationship between MnSOD Ala16Val SNP with stroke and plasmatic BDNF levels and also its influence on inflammatory, oxidative stress, apoptosis and glycolipid parameters on stroke. For this purpose, stroke patients and healthy subjects were recruited to biochemistry analysis. We analyzed glycolipid profile, IL-1, IL-6, IFN-γ and BDNF levels, as well as caspases (1 and 3) activation, oxidative stress, apoptosis, DNA damage and spasticity of stroke patients comparated whith healthy subjects. Results showed a higher proportion of VV genotype in post-stroke as compared to healthy subjects. The results also indicated that stroke patients had higher cholesterol (CHO) and glucose (GLU) levels when compared to healthy counterparts. Interestingly, V allele carriers with stroke showed higher levels of CHO and GLU levels when compared to AA stroke and healthy counterparts. Furthermore, results show that oxidative stress parameters (TBARS, levels of nitrite and nitrate (NOx), SOD and catalase activities) and DNA damage are increased in stroke group compared to healthy individuals, even after 6 months of stroke. The values of total cholesterol, LDL, IL-1, IL- 6, and INF- levels also were higher in VV post-stroke as compared to AA, AV post-stroke and control group. The triglycerides and glucose levels and caspases (1 and 3) activation were significantly higher in VV and AV post-stroke patients as compared to AA post-stroke and control group. The BDNF levels were lower in VV and AV post-stroke patients as compared to AA post-stroke and control group. The DNA damage was higher in stroke group when compared to control group. The results also showed a correlation between IL-1 and spasticity in VV post-stroke as compared to others groups. Our results suggest that polymorphism in MnSOD Ala16Val may contribute to hypercholesterolemia and higher levels of GLU, leading to alteration in neurovascular homeostasis. These events contribute to an increase in inflammatory markers, oxidative, apoptotic and in reducing BDNF, contributing to the pathophysiology of neurovascular disease.
id UFSM_339ccfc7f6e91c9056d9494cc20657cd
oai_identifier_str oai:repositorio.ufsm.br:1/17963
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardioAssociation of MnSOD ALA16VAL polymorphism with the inflammatory, apoptotics biomarkers and BDNF in patients after stroke latePolimorfismoEstresse oxidativoCitocinas inflamatóriasCaspaseDano ao DNADislipidemiaPolimorphysmOxidative stressInflammatory cytokinesCaspaseDNA damageHypercholesterolemiaCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAStroke is one of the most frequent neurologic diseases and involves various risk factors such as atherosclerosis, dyslipidemia and diabetes mellitus. Furthermore, the mechanisms of action associated with the pathophysiology of stroke involve multiple interaction pathways such as inflammation, oxidative stress, apoptosis, genetic factors and modulation of neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Studies has showed that genetics mutation as MnSOD Ala16Val single nucleotide polymorphism (SNP) to be associated to risk factors of vascular diseases, as well as with modulation of inflammation and oxidative pathways. However, little is known about the relationship between MnSOD Ala16Val SNP with stroke and plasmatic BDNF levels and also its influence on inflammatory, oxidative stress, apoptosis and glycolipid parameters on stroke. For this purpose, stroke patients and healthy subjects were recruited to biochemistry analysis. We analyzed glycolipid profile, IL-1, IL-6, IFN-γ and BDNF levels, as well as caspases (1 and 3) activation, oxidative stress, apoptosis, DNA damage and spasticity of stroke patients comparated whith healthy subjects. Results showed a higher proportion of VV genotype in post-stroke as compared to healthy subjects. The results also indicated that stroke patients had higher cholesterol (CHO) and glucose (GLU) levels when compared to healthy counterparts. Interestingly, V allele carriers with stroke showed higher levels of CHO and GLU levels when compared to AA stroke and healthy counterparts. Furthermore, results show that oxidative stress parameters (TBARS, levels of nitrite and nitrate (NOx), SOD and catalase activities) and DNA damage are increased in stroke group compared to healthy individuals, even after 6 months of stroke. The values of total cholesterol, LDL, IL-1, IL- 6, and INF- levels also were higher in VV post-stroke as compared to AA, AV post-stroke and control group. The triglycerides and glucose levels and caspases (1 and 3) activation were significantly higher in VV and AV post-stroke patients as compared to AA post-stroke and control group. The BDNF levels were lower in VV and AV post-stroke patients as compared to AA post-stroke and control group. The DNA damage was higher in stroke group when compared to control group. The results also showed a correlation between IL-1 and spasticity in VV post-stroke as compared to others groups. Our results suggest that polymorphism in MnSOD Ala16Val may contribute to hypercholesterolemia and higher levels of GLU, leading to alteration in neurovascular homeostasis. These events contribute to an increase in inflammatory markers, oxidative, apoptotic and in reducing BDNF, contributing to the pathophysiology of neurovascular disease.O acidente vascular encefálico (AVE) é uma das doenças neurológicas mais frequentes e apresenta vários fatores de risco como a aterosclerose, dislipidemia e diabetes melitus. Além disso, os mecanismos de ação associados a fisiopatologia do AVE envolvem várias vias de interação, tais como inflamação, estresse oxidativo, apoptose, fatores genéticos e modulação de fatores neurotróficos, como o fator neurotrófico cerebral (BDNF). Estudos tem mostrado que as mutações genéticas, como o polimorfismo do nucleotídeo único da superóxido dismutase manganês (MnSOD Ala16Val SNP) está associado a fatores de risco de algumas doenças cardiovasculares, assim como, a modulação das vias inflamatórias e oxidativas. Entretanto, pouco se sabe sobre a relação do polimorfismo da MnSOD Ala16Val com o AVE e com os níveis de BDNF plasmáticos, bem como, a influência da mutação genética nos parâmetros inflamatórios, de estresse oxidativo e marcadores apoptóticos nessa patologia. Dessa forma, inicialmente foram recrutados indivíduos com AVE crônico (44) e indivíduos saudáveis (44) para análise da associação do polimorfismo da MnSOD Ala16Val e o AVE. O perfil glicolipídico, níveis plasmáticos de citocinas inflamatórias (IL-1β, IL-6 e IFN-γ), caspases (1 e 3), BDNF, dano ao DNA, TBARS, níveis de nitrito e nitrato (NOx), atividades da SOD e catalase também foram avaliados nos pacientes com AVE comparando com indivíduos saudáveis (controle). Os resultados mostraram uma maior proporção do genótipo VV no grupo AVE em comparação com indivíduos saudáveis. Além disso, observamos maiores níveis de colesterol (CHO) e glicose (GLU) nos pacientes após AVE quando comparados com os indivíduos saudáveis. Interessantemente, os pacientes que apresentaram o alelo V mostraram maiores níveis de CHO e GLU quando comparados ao genótipo AA do grupo AVE e os genótipos do grupo controle. Os resultados ainda mostram que os parâmetros de estresse oxidativo (TBARS, níveis de NOx e atividades da SOD e catalase) e dano ao DNA estão aumentados no grupo AVE em relação aos indíviduos saudáveis, mesmo após 6 meses do evento isquêmico cerebral. A análise estatística mostrou, que os valores de colesterol total, LDL, IL-1β, IL-6, e os níveis de IFN- foram mais elevados nos pacientes AVE com genótipo VV em comparação com os AA e AV e com os genótipos dos indivíduos controles. Os níveis dos triglicerídeos, glicose e caspases (1 e 3) foram significativamente maiores no genótipo VV e AV no grupo AVE em comparação com o genótipo AA e com os genótipos dos indivíduos controles. Os níveis de BDNF foram menores nos genótipos VV e AV em relação ao AA dos pacientes com AVE e com os genótipos dos indivíduos controles. Os resultados também mostraram uma correlação entre IL-1β e espasticidade no genótipo VV quando comparado com AA e AV dos pacientes pós AVE. Nossos resultados sugerem que o polimorfismo na MnSOD Ala16Val pode contribuir para a hipercolesterolemia e níveis mais elevados de GLU, levando a alteração na homeostase neurovascular. Estes eventos colaboram com um aumento dos marcadores inflamatórios, oxidativos, apoptóticos e na redução de BDNF, contribuindo para a fisiopatologia da doença neurovasular.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeFighera, Michele Rechiahttp://lattes.cnpq.br/8583392747509231Cabrini, Daniela de Almeidahttp://lattes.cnpq.br/8216559706512225Santos, Gabriela Trevisan doshttp://lattes.cnpq.br/7186082133291911Ferreira, Julianohttp://lattes.cnpq.br/2694197910478313Flores, Ariane Ethur2019-08-19T16:16:05Z2019-08-19T16:16:05Z2017-07-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17963porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2019-08-20T06:02:43Zoai:repositorio.ufsm.br:1/17963Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2019-08-20T06:02:43Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
Association of MnSOD ALA16VAL polymorphism with the inflammatory, apoptotics biomarkers and BDNF in patients after stroke late
title Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
spellingShingle Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
Flores, Ariane Ethur
Polimorfismo
Estresse oxidativo
Citocinas inflamatórias
Caspase
Dano ao DNA
Dislipidemia
Polimorphysm
Oxidative stress
Inflammatory cytokines
Caspase
DNA damage
Hypercholesterolemia
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
title_full Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
title_fullStr Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
title_full_unstemmed Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
title_sort Associação do polimorfismo MnSOD ALA16VAL com os biomarcadores inflamatórios, apoptóticos e BDNF em pacientes após acidente vascular encefálico tardio
author Flores, Ariane Ethur
author_facet Flores, Ariane Ethur
author_role author
dc.contributor.none.fl_str_mv Fighera, Michele Rechia
http://lattes.cnpq.br/8583392747509231
Cabrini, Daniela de Almeida
http://lattes.cnpq.br/8216559706512225
Santos, Gabriela Trevisan dos
http://lattes.cnpq.br/7186082133291911
Ferreira, Juliano
http://lattes.cnpq.br/2694197910478313
dc.contributor.author.fl_str_mv Flores, Ariane Ethur
dc.subject.por.fl_str_mv Polimorfismo
Estresse oxidativo
Citocinas inflamatórias
Caspase
Dano ao DNA
Dislipidemia
Polimorphysm
Oxidative stress
Inflammatory cytokines
Caspase
DNA damage
Hypercholesterolemia
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Polimorfismo
Estresse oxidativo
Citocinas inflamatórias
Caspase
Dano ao DNA
Dislipidemia
Polimorphysm
Oxidative stress
Inflammatory cytokines
Caspase
DNA damage
Hypercholesterolemia
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Stroke is one of the most frequent neurologic diseases and involves various risk factors such as atherosclerosis, dyslipidemia and diabetes mellitus. Furthermore, the mechanisms of action associated with the pathophysiology of stroke involve multiple interaction pathways such as inflammation, oxidative stress, apoptosis, genetic factors and modulation of neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Studies has showed that genetics mutation as MnSOD Ala16Val single nucleotide polymorphism (SNP) to be associated to risk factors of vascular diseases, as well as with modulation of inflammation and oxidative pathways. However, little is known about the relationship between MnSOD Ala16Val SNP with stroke and plasmatic BDNF levels and also its influence on inflammatory, oxidative stress, apoptosis and glycolipid parameters on stroke. For this purpose, stroke patients and healthy subjects were recruited to biochemistry analysis. We analyzed glycolipid profile, IL-1, IL-6, IFN-γ and BDNF levels, as well as caspases (1 and 3) activation, oxidative stress, apoptosis, DNA damage and spasticity of stroke patients comparated whith healthy subjects. Results showed a higher proportion of VV genotype in post-stroke as compared to healthy subjects. The results also indicated that stroke patients had higher cholesterol (CHO) and glucose (GLU) levels when compared to healthy counterparts. Interestingly, V allele carriers with stroke showed higher levels of CHO and GLU levels when compared to AA stroke and healthy counterparts. Furthermore, results show that oxidative stress parameters (TBARS, levels of nitrite and nitrate (NOx), SOD and catalase activities) and DNA damage are increased in stroke group compared to healthy individuals, even after 6 months of stroke. The values of total cholesterol, LDL, IL-1, IL- 6, and INF- levels also were higher in VV post-stroke as compared to AA, AV post-stroke and control group. The triglycerides and glucose levels and caspases (1 and 3) activation were significantly higher in VV and AV post-stroke patients as compared to AA post-stroke and control group. The BDNF levels were lower in VV and AV post-stroke patients as compared to AA post-stroke and control group. The DNA damage was higher in stroke group when compared to control group. The results also showed a correlation between IL-1 and spasticity in VV post-stroke as compared to others groups. Our results suggest that polymorphism in MnSOD Ala16Val may contribute to hypercholesterolemia and higher levels of GLU, leading to alteration in neurovascular homeostasis. These events contribute to an increase in inflammatory markers, oxidative, apoptotic and in reducing BDNF, contributing to the pathophysiology of neurovascular disease.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-01
2019-08-19T16:16:05Z
2019-08-19T16:16:05Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17963
url http://repositorio.ufsm.br/handle/1/17963
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922178403663872